This work presents an optimization technique to determine the inspection, warranty period, and preventive maintenance policies for micromachines suffering from degradation. Specifically, wear degradation is considered, which is a common failure process for many Micro-Electro-Mechanical Systems (MEMS). The proposed mathematical model examines the impact of quality control on reliability and the duration of the warranty period given by the manufacturer or the supplier to the customer. Each of the above processes creates implementation costs. All the individual costs are integrated into a single measure, which is used to build the model and derive the optimal parameters of the quality and maintenance policies. The implementation of various levels of the quality, warranty, and maintenance policies are compared with their optimum level options to highlight their contribution to the assurance and improving product quality. To the authors' best knowledge, the introduction of a warranty period is implemented for the first time in the open literature concerning this type of optimization model for MEMs and surely can bring additional advantages to their quality promotion strategy. The proposed optimization tool provides a comprehensive simultaneous answer to the optimal selection of all the values of the design variables determining the overall maintenance and quality management approach.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692908 | PMC |
http://dx.doi.org/10.3390/mi13111899 | DOI Listing |
J Appl Stat
May 2024
Department of Aviation Management, Republic of China Air Force Academy, Kaohsiung, Taiwan.
Ensuring products maintain their normal function during the warranty period is essential for companies to control warranty costs and sustain their brand reputation. A variables acceptance sampling (VAS) plan based on the lifetime performance index (LPI) is a practical technology for verifying product lifetimes because it can provide the number of failures required for life testing and the acceptance criterion for lot disposition. Recently, an LPI-based variables quick-switch sampling (VQSS) system has been developed to improve the sampling efficiency.
View Article and Find Full Text PDFEur Heart J Cardiovasc Imaging
November 2024
Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
Aims: Stress echocardiography is widely used to assess patients with chest pain. The clinical value of a positive or negative test result to inform on likely longer-term outcomes when applied in real world practice across a healthcare system has not been previously reported.
Methods And Results: 5503 patients recruited across 32 UK NHS hospitals between 2018 and 2022, participating in the EVAREST/BSE-NSTEP prospective cohort study, with data on medical outcomes up to 2023 available from NHS England were included in analysis.
Nanomaterials (Basel)
October 2024
Department of Physics, University of North Texas, Denton, TX 76203, USA.
Encapsulating CsPbBr quantum dots in silicon nano-sheets not only stabilizes the halide perovskite, but also takes advantage of the nano-sheet for a compatible integration with the traditional silicon semiconductor. Here, we report the preparation of un-passivated CsPbBr ellipsoidal nanocrystals and pseudo-spherical quantum dots in silicon nano-sheets and their enhanced photoluminescence (PL). For a sample with low concentrations of quantum dots in silicon nano-sheets, the emission from CsPbBr pseudo-spherical quantum dots is quenched and is dominated with Pb ion/silicene emission, which is very stable during the whole measurement period.
View Article and Find Full Text PDFCirc Cardiovasc Imaging
September 2024
Lundquist Institute, Harbor-UCLA Medical Center, Torrance, CA (K.I., S.S., S. Krishnan, T.B., S. Kianoush, J.A.-B., V.S.M., M.J.B.).
Background: For individuals with a coronary artery calcium (CAC) score of 0, CAC rescans at appropriate timings are recommended, depending on individual risk profiles. Although nonalcoholic fatty liver disease, recently redefined as metabolic-associated fatty liver disease, is a risk factor for atherosclerotic cardiovascular disease events, its relationship with the warranty period of a CAC score of 0 has not been elucidated.
Methods: A total of 1944 subjects from the MESA (Multi-Ethnic Study of Atherosclerosis) with a baseline CAC score of 0, presence or absence of nonalcoholic hepatic steatosis, and at least 1 follow-up computed tomography scan were included.
J Anim Sci
January 2024
Department of Animal Sciences, Center for Nutrition and Pregnancy, North Dakota State University, Fargo, ND 58108, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!